Systematic review evaluates the efficacy and safety of NAC in ischemic stroke, suggesting potential benefits.
Current ischemic stroke treatment protocols do not include the use of neuroprotective agents. Preclinical studies suggest that N-acetylcysteine (NAC) may offer neuroprotection through its antioxidant, anti-inflammatory, and excitotoxicity-mediating effects. The aim of this systematic review was to evaluate the safety and efficacy of NAC in the treatment of ischemic stroke.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: